• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.
View the full Corporate Spotlight arrow Created with Sketch.

director sees

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAC
2019 SP
2
16:03 80 21K
16:03 Last post  Infidel75 Comments Created with Sketch.  80  Views Created with Sketch.  21K 
RAC 15:47 4 356
15:47 Last post  sjb71 Comments Created with Sketch.  4  Views Created with Sketch.  356 
RAC
News: RAC Race Oncology Issues Bisantrene Investigational New Drug Application Update
14:45 0 41
14:45 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  41 
RAC 12/04/19 0 240
12/04/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  240 
RAC 26/03/19 7 1.8K
26/03/19 Last post  Hillyhawkie Comments Created with Sketch.  7  Views Created with Sketch.  1.8K 
RAC
RAC (ASX) Corporate Spotlight Updates
25/03/19 3 858
25/03/19 Last post  Corporate Spotlight Comments Created with Sketch.  3  Views Created with Sketch.  858 
RAC 13/03/19 1 610
13/03/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  610 
RAC 27/02/19 1 505
27/02/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  505 
RAC 25/02/19 4 1.6K
25/02/19 Last post  EWexplorer Comments Created with Sketch.  4  Views Created with Sketch.  1.6K 
RAC 14/02/19 0 294
14/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  294 
RAC 12/02/19 1 607
12/02/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  607 
RAC 12/02/19 1 552
12/02/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  552 
RAC 12/02/19 0 263
12/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  263 
RAC 12/02/19 0 221
12/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  221 
RAC 08/02/19 3 1.0K
08/02/19 Last post  EddyG Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 
RAC 31/01/19 2 3.1K
31/01/19 Last post  Infidel75 Comments Created with Sketch.  2  Views Created with Sketch.  3.1K 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Bisantrene IND Update
24 Apr 13:34
 
Appendix 4C - quarterly
12 Apr 16:41
 
Race files Bisantrene IND with FDA
25 Mar 09:31
 
Appendix 3B
13 Mar 19:04
 
Appendix 4D & Half-Year Financial Statements
27 Feb 16:19
 
Principal Investigator appointed for Bisantrene
25 Feb 09:10
 
View More arrow Created with Sketch.
(20min delay)
Last
6.5¢
Change
-0.009(12.2%)
Mkt cap ! $6.455M
Open High Low Value Volume
7.4¢ 7.4¢ 6.5¢ $6.151K 87.45K

Buyers (Bids)

No. Vol. Price($)
1 10000 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 73996 1
View Market Depth
Last update - 15.16pm 24/04/2019 (20 minute delay) ?
(live)
Last
6.5¢
  Change
-0.009 ( 11.0 %)
Open High Low Volume
7.3¢ 7.3¢ 6.5¢ 23558
Last updated 15.16pm 24/04/2019 (live) ?
RAC (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.